Summary of clinical and social outcomes in juvenile-onset (JoAS) versus adult-onset ankylosing spondylitis (AoAS).
Domain | Characteristic | JoAS More Likely/Higher/Worse (Ref. No.) | Equal JoAS & AoAS (Ref. No.) | AoAS More Likely/Higher/Worse (Ref. No.) |
---|---|---|---|---|
Treatment | ||||
NSAID use | (13) | |||
Treatments | (5) | |||
Medication use | (9, 14) | |||
Employment | ||||
Income | Better (6) | |||
Socioeconomic status | (5) | |||
Educational level | Better (6) | (12, 14) | Better (5) | |
In school or employment | (13) | |||
In full-time employment | (9) | |||
Unemployable due to AS | (13) | |||
Work disability | (6) | (14) | ||
Health-related status | ||||
HAQ | (14) | (7) | ||
Limitation of lifestyle due to AS | (13) | |||
BASG | (11) | (16) | ||
PGA | NS (16) | |||
Quality of life (SF-36) | (5) | (7) | ||
ASQoL | (12) | (7) | ||
Fatigue | BASDAI (12) | FACIT (7) | ||
Modified Arthritis Impact Measurement Scales (AIMS; includes depression, anxiety, physical activity, pain, impact, social activity) | (9) | |||
Social activity domain of AIMS | (9) |
NS: not statistically significant; AS: ankylosing spondylitis; ASQoL: AS quality of life index; FACIT: Functional Assessment of Chronic Illness Therapy Fatigue scale; HAQ: Health Assessment Questionnaire; PGA: Patient Global Assessment; SF-36: Medical Outcome Study Short Form-36; AIMS: Modified Arthritis Impact Measurement Scales; NSAID: nonsteroidal antiinflammatory drug; BASG: Bath AS Patient Global Score.